Fingerprint
Dive into the research topics of 'Cost-effectiveness of omalizumab in adults with severe asthma: Results from the Asthma Policy Model'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Cost-effectiveness of omalizumab in adults with severe asthma: Results from the Asthma Policy Model
Ann C. Wu, A. David Paltiel, Karen M. Kuntz, Scott T. Weiss, Anne L. Fuhlbrigge
Research output: Contribution to journal › Article › peer-review
99
Scopus
citations